163 related articles for article (PubMed ID: 1981582)
1. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
Groenewegen WA; Heptinstall S
J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582
[TBL] [Abstract][Full Text] [Related]
2. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.
Heptinstall S; White A; Williamson L; Mitchell JR
Lancet; 1985 May; 1(8437):1071-4. PubMed ID: 2860288
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
4. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.
Heptinstall S; Groenewegen WA; Spangenberg P; Loesche W
J Pharm Pharmacol; 1987 Jun; 39(6):459-65. PubMed ID: 2886604
[TBL] [Abstract][Full Text] [Related]
5. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).
Makheja AN; Bailey JM
Prostaglandins Leukot Med; 1982 Jun; 8(6):653-60. PubMed ID: 6810384
[TBL] [Abstract][Full Text] [Related]
6. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
7. Feverfew--an antithrombotic drug?
Loesche W; Mazurov AV; Voyno-Yasenetskaya TA; Groenewegen WA; Heptinstall S; Repin VS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):181-4. PubMed ID: 2459017
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro.
Brown AM; Edwards CM; Davey MR; Power JB; Lowe KC
J Pharm Pharmacol; 1997 May; 49(5):558-61. PubMed ID: 9178194
[TBL] [Abstract][Full Text] [Related]
10. The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.
Sahler J; Bernard JJ; Spinelli SL; Blumberg N; Phipps RP
Thromb Res; 2011 May; 127(5):426-34. PubMed ID: 21272923
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
12. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation in patients using feverfew for migraine.
Biggs MJ; Johnson ES; Persaud NP; Ratcliffe DM
Lancet; 1982 Oct; 2(8301):776. PubMed ID: 6125851
[No Abstract] [Full Text] [Related]
14. Effects of a garlic-derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets.
Srivastava KC; Tyagi OD
Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):587-95. PubMed ID: 8415808
[TBL] [Abstract][Full Text] [Related]
15. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
Joseph S; Krishnamurthi S; Kakkar VV
Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996
[TBL] [Abstract][Full Text] [Related]
16. Extracts from two frequently consumed spices--cumin (Cuminum cyminum) and turmeric (Curcuma longa)--inhibit platelet aggregation and alter eicosanoid biosynthesis in human blood platelets.
Srivastava KC
Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):57-64. PubMed ID: 2503839
[TBL] [Abstract][Full Text] [Related]
17. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets.
Loesche W; Groenewegen WA; Krause S; Spangenberg P; Heptinstall S
Biomed Biochim Acta; 1988; 47(10-11):S241-3. PubMed ID: 3248111
[TBL] [Abstract][Full Text] [Related]
18. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
20. Feverfew extracts and parthenolide irreversibly inhibit vascular responses of the rabbit aorta.
Barsby RW; Salan U; Knight DW; Hoult JR
J Pharm Pharmacol; 1992 Sep; 44(9):737-40. PubMed ID: 1360525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
